TuisHYPMY • OTCMKTS
add
Hypera ADR
Vorige sluiting
$3,36
Dagwisseling
$3,53 - $3,67
Jaarwisseling
$3,36 - $7,90
Markkapitalisasie
13,12 mjd BRL
Gemiddelde volume
463,31 k
Marknuus
Reuters
4 uur gelede
Goldman Sachs forecasts S&P 500 target of 6500 for 2025-end, joins Morgan
Stanley
0,39%
0,21%
0,94%
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (BRL) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 1,92 mjd | -10,41% |
Bedryfskoste | 696,64 m | 6,57% |
Netto inkomste | 376,38 m | -24,64% |
Netto winsgrens | 19,64 | -15,89% |
Wins per aandeel | 0,59 | -24,57% |
EBITDA | 491,91 m | -35,40% |
Effektiewe belastingkoers | -25,60% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (BRL) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 3,21 mjd | 44,64% |
Totale bates | 25,87 mjd | 6,61% |
Totale aanspreeklikheid | 13,65 mjd | 6,09% |
Totale ekwiteit | 12,22 mjd | — |
Uitstaande aandele | 632,68 m | — |
Prys om te bespreek | 0,17 | — |
Opbrengs op bates | 4,38% | — |
Opbrengs op kapitaal | 4,97% | — |
Kontantvloei
Netto kontantverandering
| (BRL) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 376,38 m | -24,64% |
Kontant van bedrywe | 738,07 m | 1,89% |
Kontant van beleggings | -137,66 m | 42,05% |
Kontant van finansiering | -227,90 m | 44,13% |
Netto kontantverandering | 372,51 m | 372,05% |
Beskikbare kontantvloei | 397,31 m | 74,43% |
Meer oor
Hypera Pharma is a Brazilian multinational pharmaceutical
company and is the largest Brazilian pharmaceutical company by market capitalization. Headquartered in São Paulo, its business include pharmaceuticals, consumer healthcare and cosmetics products, and biotechnology products. Wikipedia
Gestig
2001
Hoofkwartier
Webwerf
Werknemers
10 301
